Decade in review-stroke: Progress in acute ischaemic stroke treatment and prevention

Nature Reviews Neurology

Volumn 11, Issue 11, 2015, Pages 619-620

  Romano, Jose G ^a   Sacco, Ralph L ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALTEPLASE; APIXABAN; DABIGATRAN; EDOXABAN; RIVAROXABAN; WARFARIN;

ATRIAL FIBRILLATION; BLOOD CLOT LYSIS; BRAIN ISCHEMIA; CAROTID ARTERY OBSTRUCTION; CEREBROVASCULAR ACCIDENT; COMPUTED TOMOGRAPHIC ANGIOGRAPHY; DIABETES MELLITUS; ELECTROCARDIOGRAPHY MONITORING; EMERGENCY CARE; ENDOVASCULAR SURGERY; HEALTH CARE ACCESS; HEALTH CARE POLICY; HEALTH DISPARITY; HEART RHYTHM; HUMAN; HYPERTENSION; MECHANICAL ENDOVASCULAR RECANALIZATION; MIDDLE CEREBRAL ARTERY; NEUROPROTECTION; NOTE; NUCLEAR MAGNETIC RESONANCE IMAGING; OBESITY; OUTCOME ASSESSMENT; PHYSICAL INACTIVITY; PREVALENCE; PRIORITY JOURNAL; RANKIN SCALE; RECANALIZATION; RISK ASSESSMENT; RISK FACTOR; SCORING SYSTEM; SYMPTOM; TISSUE PERFUSION; ACUTE DISEASE; CLINICAL TRIAL (TOPIC); STROKE;

ACUTE DISEASE; BRAIN ISCHEMIA; CLINICAL TRIALS AS TOPIC; HUMANS; STROKE;

EID: 84947031660     PISSN: 17594758     EISSN: 17594766     Source Type: Journal    
DOI: 10.1038/nrneurol.2015.199     Document Type: Note

References (10)

1. Hacke, W. et al. Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke. N. Engl. J. Med. 359, 1317-1329 (2008).
2. IST-3 collaborative group. et al. The benefits and harms of intravenous thrombolysis with recombinant tissue plasminogen activator within 6 h of acute ischaemic stroke (the third international stroke trial [IST-3]): a randomized controlled trial. Lancet 379, 2352-2363 (2012).
3. Emberson, J. et al. Effect of treatment delay, age, and stroke severity on the effects of intravenous thrombolysis with alteplase for acute ischaemic stroke: a meta-analysis of individual patient data from randomised trials. Lancet 384, 1929-1935 (2014).
4. Falk-Delgado, A., Kuntze Söderqvist, A., Fransén, J. & Falk-Delgado, A. Improved clinical outcome 3 months after endovascular treatment, including thrombectomy, in patients with acute ischemic stroke: a meta-analysis. J. Neurointerv. Surg. http://dx.doi.org/ 10.1136/neurintsurg-2015-011835.
5. Prabhakaran, S., Ruff, I. & Bernstein, R. A. Acute stroke intervention: a systematic review. JAMA 313, 1451-1462 (2015).
6. Powers, W. J. et al. 2015 AHA/ASA focused update of the 2013 guidelines for the early management of patients with acute ischemic stroke regarding endovascular treatment: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke http://dx.doi.org/ 10.1161/STR.0000000000000074.
7. Ruff, C. T. et al. Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials. Lancet 383, 955-962 (2014).
8. Kirchhof, P. et al. Atrial fibrillation guidelines across the Atlantic: a comparison of the current recommendations of the European Society of Cardiology/European Heart Rhythm Association/European Association of Cardiothoracic Surgeons, the American College of Cardiology Foundation/American Heart Association/Heart Rhythm Society, and the Canadian Cardiovascular Society. Eur. Heart J. 34, 1471-1474 (2013).
9. Sanna, T. et al. Cryptogenic stroke and underlying atrial fibrillation. N. Engl. J. Med. 370, 2478-2486 (2014).
10. Feigin, V. L. et al. Global and regional burden of stroke during 1990-2010: findings from the Global Burden of Disease Study 2010. Lancet 383, 245-254 (2014).